Identification of the CIMP-like subtype and aberrant methylation of members of the chromosomal segregation and spindle assembly pathways in esophageal adenocarcinoma

Krause L, Nones K, Loffler KA, Nancarrow D, Oey H, Tang YH, Wayte NJ, Patch AM, Patel K, Brosda S, Manning S, et al. (2016)
Carcinogenesis 37(4): 356-365.

Zeitschriftenaufsatz | Veröffentlicht | Englisch
 
Download
Es wurden keine Dateien hochgeladen. Nur Publikationsnachweis!
Autor*in
Krause, Lutz; Nones, Katia; Loffler, Kelly A.; Nancarrow, Derek; Oey, Harald; Tang, Yup Hang; Wayte, Nicola J.; Patch, Ann Marie; Patel, Kalpana; Brosda, SandraUniBi; Manning, Suzanne; Lampe, Guy
Alle
Erscheinungsjahr
2016
Zeitschriftentitel
Carcinogenesis
Band
37
Ausgabe
4
Seite(n)
356-365
ISSN
0143-3334
eISSN
1460-2180
Page URI
https://pub.uni-bielefeld.de/record/2900421

Zitieren

Krause L, Nones K, Loffler KA, et al. Identification of the CIMP-like subtype and aberrant methylation of members of the chromosomal segregation and spindle assembly pathways in esophageal adenocarcinoma. Carcinogenesis. 2016;37(4):356-365.
Krause, L., Nones, K., Loffler, K. A., Nancarrow, D., Oey, H., Tang, Y. H., Wayte, N. J., et al. (2016). Identification of the CIMP-like subtype and aberrant methylation of members of the chromosomal segregation and spindle assembly pathways in esophageal adenocarcinoma. Carcinogenesis, 37(4), 356-365. doi:10.1093/carcin/bgw018
Krause, Lutz, Nones, Katia, Loffler, Kelly A., Nancarrow, Derek, Oey, Harald, Tang, Yup Hang, Wayte, Nicola J., et al. 2016. “Identification of the CIMP-like subtype and aberrant methylation of members of the chromosomal segregation and spindle assembly pathways in esophageal adenocarcinoma”. Carcinogenesis 37 (4): 356-365.
Krause, L., Nones, K., Loffler, K. A., Nancarrow, D., Oey, H., Tang, Y. H., Wayte, N. J., Patch, A. M., Patel, K., Brosda, S., et al. (2016). Identification of the CIMP-like subtype and aberrant methylation of members of the chromosomal segregation and spindle assembly pathways in esophageal adenocarcinoma. Carcinogenesis 37, 356-365.
Krause, L., et al., 2016. Identification of the CIMP-like subtype and aberrant methylation of members of the chromosomal segregation and spindle assembly pathways in esophageal adenocarcinoma. Carcinogenesis, 37(4), p 356-365.
L. Krause, et al., “Identification of the CIMP-like subtype and aberrant methylation of members of the chromosomal segregation and spindle assembly pathways in esophageal adenocarcinoma”, Carcinogenesis, vol. 37, 2016, pp. 356-365.
Krause, L., Nones, K., Loffler, K.A., Nancarrow, D., Oey, H., Tang, Y.H., Wayte, N.J., Patch, A.M., Patel, K., Brosda, S., Manning, S., Lampe, G., Clouston, A., Thomas, J., Stoye, J., Hussey, D.J., Watson, D.I., Lord, R.V., Phillips, W.A., Gotley, D., Smithers, B.M., Whiteman, D.C., Hayward, N.K., Grimmond, S.M., Waddell, N., Barbour, A.P.: Identification of the CIMP-like subtype and aberrant methylation of members of the chromosomal segregation and spindle assembly pathways in esophageal adenocarcinoma. Carcinogenesis. 37, 356-365 (2016).
Krause, Lutz, Nones, Katia, Loffler, Kelly A., Nancarrow, Derek, Oey, Harald, Tang, Yup Hang, Wayte, Nicola J., Patch, Ann Marie, Patel, Kalpana, Brosda, Sandra, Manning, Suzanne, Lampe, Guy, Clouston, Andrew, Thomas, Janine, Stoye, Jens, Hussey, Damian J., Watson, David I., Lord, Reginald V., Phillips, Wayne A., Gotley, David, Smithers, B. Mark, Whiteman, David C., Hayward, Nicholas K., Grimmond, Sean M., Waddell, Nicola, and Barbour, Andrew P. “Identification of the CIMP-like subtype and aberrant methylation of members of the chromosomal segregation and spindle assembly pathways in esophageal adenocarcinoma”. Carcinogenesis 37.4 (2016): 356-365.

9 Zitationen in Europe PMC

Daten bereitgestellt von Europe PubMed Central.

A gene expression assay for simultaneous measurement of microsatellite instability and anti-tumor immune activity.
Danaher P, Warren S, Ong S, Elliott N, Cesano A, Ferree S., J Immunother Cancer 7(1), 2019
PMID: 30665466
Stromal-derived interleukin 6 drives epithelial-to-mesenchymal transition and therapy resistance in esophageal adenocarcinoma.
Ebbing EA, van der Zalm AP, Steins A, Creemers A, Hermsen S, Rentenaar R, Klein M, Waasdorp C, Hooijer GKJ, Meijer SL, Krishnadath KK, Punt CJA, van Berge Henegouwen MI, Gisbertz SS, van Delden OM, Hulshof MCCM, Medema JP, van Laarhoven HWM, Bijlsma MF., Proc Natl Acad Sci U S A 116(6), 2019
PMID: 30670657
Molecular landscape of esophageal cancer: implications for early detection and personalized therapy.
Talukdar FR, di Pietro M, Secrier M, Moehler M, Goepfert K, Lima SSC, Pinto LFR, Hendricks D, Parker MI, Herceg Z., Ann N Y Acad Sci 1434(1), 2018
PMID: 29917250
FOXF2 promoter methylation is associated with prognosis in esophageal squamous cell carcinoma.
Chen X, Hu H, Liu J, Yang Y, Liu G, Ying X, Chen Y, Li B, Ye C, Wu D, Duan S., Tumour Biol 39(2), 2017
PMID: 28222662
Prognostic significance of SOCS3 and its biological function in colorectal cancer.
Chu Q, Shen D, He L, Wang H, Liu C, Zhang W., Gene 627(), 2017
PMID: 28603075
Fibroblasts derived from oesophageal adenocarcinoma differ in DNA methylation profile from normal oesophageal fibroblasts.
Smith E, Palethorpe HM, Hayden AL, Young JP, Underwood TJ, Drew PA., Sci Rep 7(1), 2017
PMID: 28611465
Identification of a key role of widespread epigenetic drift in Barrett's esophagus and esophageal adenocarcinoma.
Luebeck EG, Curtius K, Hazelton WD, Maden S, Yu M, Thota PN, Patil DT, Chak A, Willis JE, Grady WM., Clin Epigenetics 9(), 2017
PMID: 29046735
The characterization of an intestine-like genomic signature maintained during Barrett's-associated adenocarcinogenesis reveals an NR5A2-mediated promotion of cancer cell survival.
Duggan SP, Behan FM, Kirca M, Zaheer A, McGarrigle SA, Reynolds JV, Vaz GM, Senge MO, Kelleher D., Sci Rep 6(), 2016
PMID: 27586588

51 References

Daten bereitgestellt von Europe PubMed Central.

Fields of aberrant CpG island hypermethylation in Barrett's esophagus and associated adenocarcinoma.
Eads CA, Lord RV, Kurumboor SK, Wickramasinghe K, Skinner ML, Long TI, Peters JH, DeMeester TR, Danenberg KD, Danenberg PV, Laird PW, Skinner KA., Cancer Res. 60(18), 2000
PMID: 11016622
The fundamental role of epigenetic events in cancer.
Jones PA, Baylin SB., Nat. Rev. Genet. 3(6), 2002
PMID: 12042769
The power and the promise of DNA methylation markers.
Laird PW., Nat. Rev. Cancer 3(4), 2003
PMID: 12671664
Prognostic importance of promoter hypermethylation of multiple genes in esophageal adenocarcinoma.
Brock MV, Gou M, Akiyama Y, Muller A, Wu TT, Montgomery E, Deasel M, Germonpre P, Rubinson L, Heitmiller RF, Yang SC, Forastiere AA, Baylin SB, Herman JG., Clin. Cancer Res. 9(8), 2003
PMID: 12912936
The spindle checkpoint, aneuploidy, and cancer.
Bharadwaj R, Yu H., Oncogene 23(11), 2004
PMID: 15021889
Aberrant methylation of secreted frizzled-related protein genes in esophageal adenocarcinoma and Barrett's esophagus.
Zou H, Molina JR, Harrington JJ, Osborn NK, Klatt KK, Romero Y, Burgart LJ, Ahlquist DA., Int. J. Cancer 116(4), 2005
PMID: 15825175
Genetic clonal diversity predicts progression to esophageal adenocarcinoma.
Maley CC, Galipeau PC, Finley JC, Wongsurawat VJ, Li X, Sanchez CA, Paulson TG, Blount PL, Risques RA, Rabinovitch PS, Reid BJ., Nat. Genet. 38(4), 2006
PMID: 16565718
CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer.
Weisenberger DJ, Siegmund KD, Campan M, Young J, Long TI, Faasse MA, Kang GH, Widschwendter M, Weener D, Buchanan D, Koh H, Simms L, Barker M, Leggett B, Levine J, Kim M, French AJ, Thibodeau SN, Jass J, Haile R, Laird PW., Nat. Genet. 38(7), 2006
PMID: 16804544
Does aneuploidy cause cancer?
Weaver BA, Cleveland DW., Curr. Opin. Cell Biol. 18(6), 2006
PMID: 17046232
Methylation of SOCS-3 and SOCS-1 in the carcinogenesis of Barrett's adenocarcinoma.
Tischoff I, Hengge UR, Vieth M, Ell C, Stolte M, Weber A, Schmidt WE, Tannapfel A., Gut 56(8), 2007
PMID: 17376806
Hypermethylation of the nel-like 1 gene is a common and early event and is associated with poor prognosis in early-stage esophageal adenocarcinoma.
Jin Z, Mori Y, Yang J, Sato F, Ito T, Cheng Y, Paun B, Hamilton JP, Kan T, Olaru A, David S, Agarwal R, Abraham JM, Beer D, Montgomery E, Meltzer SJ., Oncogene 26(43), 2007
PMID: 17452981
Risk of mortality and cancer incidence in Barrett's esophagus.
Cook MB, Wild CP, Everett SM, Hardie LJ, Bani-Hani KE, Martin IG, Forman D., Cancer Epidemiol. Biomarkers Prev. 16(10), 2007
PMID: 17890521
Hypermethylation of tachykinin-1 is a potential biomarker in human esophageal cancer.
Jin Z, Olaru A, Yang J, Sato F, Cheng Y, Kan T, Mori Y, Mantzur C, Paun B, Hamilton JP, Ito T, Wang S, David S, Agarwal R, Beer DG, Abraham JM, Meltzer SJ., Clin. Cancer Res. 13(21), 2007
PMID: 17975140
Hypermethylation of the somatostatin promoter is a common, early event in human esophageal carcinogenesis.
Jin Z, Mori Y, Hamilton JP, Olaru A, Sato F, Yang J, Ito T, Kan T, Agarwal R, Meltzer SJ., Cancer 112(1), 2008
PMID: 17999418
Hypermethylation of the AKAP12 promoter is a biomarker of Barrett's-associated esophageal neoplastic progression.
Jin Z, Hamilton JP, Yang J, Mori Y, Olaru A, Sato F, Ito T, Kan T, Cheng Y, Paun B, David S, Beer DG, Agarwal R, Abraham JM, Meltzer SJ., Cancer Epidemiol. Biomarkers Prev. 17(1), 2008
PMID: 18199717
lumi: a pipeline for processing Illumina microarray.
Du P, Kibbe WA, Lin SM., Bioinformatics 24(13), 2008
PMID: 18467348
Frequent switching of Polycomb repressive marks and DNA hypermethylation in the PC3 prostate cancer cell line.
Gal-Yam EN, Egger G, Iniguez L, Holster H, Einarsson S, Zhang X, Lin JC, Liang G, Jones PA, Tanay A., Proc. Natl. Acad. Sci. U.S.A. 105(35), 2008
PMID: 18753622
Similarity of aberrant DNA methylation in Barrett's esophagus and esophageal adenocarcinoma.
Smith E, De Young NJ, Pavey SJ, Hayward NK, Nancarrow DJ, Whiteman DC, Smithers BM, Ruszkiewicz AR, Clouston AD, Gotley DC, Devitt PG, Jamieson GG, Drew PA., Mol. Cancer 7(), 2008
PMID: 18831746
rtracklayer: an R package for interfacing with genome browsers.
Lawrence M, Gentleman R, Carey V., Bioinformatics 25(14), 2009
PMID: 19468054
Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma.
Noushmehr H, Weisenberger DJ, Diefes K, Phillips HS, Pujara K, Berman BP, Pan F, Pelloski CE, Sulman EP, Bhat KP, Verhaak RG, Hoadley KA, Hayes DN, Perou CM, Schmidt HK, Ding L, Wilson RK, Van Den Berg D, Shen H, Bengtsson H, Neuvial P, Cope LM, Buckley J, Herman JG, Baylin SB, Laird PW, Aldape K; Cancer Genome Atlas Research Network., Cancer Cell 17(5), 2010
PMID: 20399149
Epigenetic and genetic silencing of CHFR in esophageal adenocarcinomas.
Soutto M, Peng D, Razvi M, Ruemmele P, Hartmann A, Roessner A, Schneider-Stock R, El-Rifai W., Cancer 116(17), 2010
PMID: 20564104
Cancer statistics, 2010.
Jemal A, Siegel R, Xu J, Ward E., CA Cancer J Clin 60(5), 2010
PMID: 20610543
Widespread hypomethylation occurs early and synergizes with gene amplification during esophageal carcinogenesis.
Alvarez H, Opalinska J, Zhou L, Sohal D, Fazzari MJ, Yu Y, Montagna C, Montgomery EA, Canto M, Dunbar KB, Wang J, Roa JC, Mo Y, Bhagat T, Ramesh KH, Cannizzaro L, Mollenhauer J, Thompson RF, Suzuki M, Meltzer SJ, Meltzer S, Melnick A, Greally JM, Maitra A, Verma A., PLoS Genet. 7(3), 2011
PMID: 21483804
Mitotic catastrophe: a mechanism for avoiding genomic instability.
Vitale I, Galluzzi L, Castedo M, Kroemer G., Nat. Rev. Mol. Cell Biol. 12(6), 2011
PMID: 21527953
DNA methylation profiling in Barrett's esophagus and esophageal adenocarcinoma reveals unique methylation signatures and molecular subclasses.
Kaz AM, Wong CJ, Luo Y, Virgin JB, Washington MK, Willis JE, Leidner RS, Chak A, Grady WM., Epigenetics 6(12), 2011
PMID: 22139570
Genome-scale analysis of aberrant DNA methylation in colorectal cancer.
Hinoue T, Weisenberger DJ, Lange CP, Shen H, Byun HM, Van Den Berg D, Malik S, Pan F, Noushmehr H, van Dijk CM, Tollenaar RA, Laird PW., Genome Res. 22(2), 2011
PMID: 21659424
Aberrant vimentin methylation is characteristic of upper gastrointestinal pathologies.
Moinova H, Leidner RS, Ravi L, Lutterbaugh J, Barnholtz-Sloan JS, Chen Y, Chak A, Markowitz SD, Willis JE., Cancer Epidemiol. Biomarkers Prev. 21(4), 2012
PMID: 22315367
Comprehensive molecular characterization of human colon and rectal cancer.
Cancer Genome Atlas Network, Muzny DM, Bainbridge MN, Chang K, Dinh HH, Drummond JA, Fowler G, Kovar CL, Lewis LR, Morgan MB, Newsham IF, Reid JG, Santibanez J, Shinbrot E, Trevino LR, Wu YQ, Wang M, Gunaratne P, Donehower LA, Creighton CJ, Wheeler DA, Gibbs RA, Lawrence MS, Voet D, Jing R, Cibulskis K, Sivachenko A, Stojanov P, McKenna A, Lander ES, Gabriel S, Getz G, Ding L, Fulton RS, Koboldt DC, Wylie T, Walker J, Dooling DJ, Fulton L, Delehaunty KD, Fronick CC, Demeter R, Mardis ER, Wilson RK, Chu A, Chun HJ, Mungall AJ, Pleasance E, Robertson A, Stoll D, Balasundaram M, Birol I, Butterfield YS, Chuah E, Coope RJ, Dhalla N, Guin R, Hirst C, Hirst M, Holt RA, Lee D, Li HI, Mayo M, Moore RA, Schein JE, Slobodan JR, Tam A, Thiessen N, Varhol R, Zeng T, Zhao Y, Jones SJ, Marra MA, Bass AJ, Ramos AH, Saksena G, Cherniack AD, Schumacher SE, Tabak B, Carter SL, Pho NH, Nguyen H, Onofrio RC, Crenshaw A, Ardlie K, Beroukhim R, Winckler W, Getz G, Meyerson M, Protopopov A, Zhang J, Hadjipanayis A, Lee E, Xi R, Yang L, Ren X, Zhang H, Sathiamoorthy N, Shukla S, Chen PC, Haseley P, Xiao Y, Lee S, Seidman J, Chin L, Park PJ, Kucherlapati R, Auman JT, Hoadley KA, Du Y, Wilkerson MD, Shi Y, Liquori C, Meng S, Li L, Turman YJ, Topal MD, Tan D, Waring S, Buda E, Walsh J, Jones CD, Mieczkowski PA, Singh D, Wu J, Gulabani A, Dolina P, Bodenheimer T, Hoyle AP, Simons JV, Soloway M, Mose LE, Jefferys SR, Balu S, O'Connor BD, Prins JF, Chiang DY, Hayes D, Perou CM, Hinoue T, Weisenberger DJ, Maglinte DT, Pan F, Berman BP, Van Den Berg DJ, Shen H, Triche T Jr, Baylin SB, Laird PW, Getz G, Noble M, Voet D, Saksena G, Gehlenborg N, DiCara D, Zhang J, Zhang H, Wu CJ, Liu SY, Shukla S, Lawrence MS, Zhou L, Sivachenko A, Lin P, Stojanov P, Jing R, Park RW, Nazaire MD, Robinson J, Thorvaldsdottir H, Mesirov J, Park PJ, Chin L, Thorsson V, Reynolds SM, Bernard B, Kreisberg R, Lin J, Iype L, Bressler R, Erkkila T, Gundapuneni M, Liu Y, Norberg A, Robinson T, Yang D, Zhang W, Shmulevich I, de Ronde JJ, Schultz N, Cerami E, Ciriello G, Goldberg AP, Gross B, Jacobsen A, Gao J, Kaczkowski B, Sinha R, Aksoy B, Antipin Y, Reva B, Shen R, Taylor BS, Chan TA, Ladanyi M, Sander C, Akbani R, Zhang N, Broom BM, Casasent T, Unruh A, Wakefield C, Hamilton SR, Cason R, Baggerly KA, Weinstein JN, Haussler D, Benz CC, Stuart JM, Benz SC, Sanborn J, Vaske CJ, Zhu J, Szeto C, Scott GK, Yau C, Ng S, Goldstein T, Ellrott K, Collisson E, Cozen AE, Zerbino D, Wilks C, Craft B, Spellman P, Penny R, Shelton T, Hatfield M, Morris S, Yena P, Shelton C, Sherman M, Paulauskis J, Gastier-Foster JM, Bowen J, Ramirez NC, Black A, Pyatt R, Wise L, White P, Bertagnolli M, Brown J, Chan TA, Chu GC, Czerwinski C, Denstman F, Dhir R, Dorner A, Fuchs CS, Guillem JG, Iacocca M, Juhl H, Kaufman A, Kohl B 3rd, Van Le X, Mariano MC, Medina EN, Meyers M, Nash GM, Paty PB, Petrelli N, Rabeno B, Richards WG, Solit D, Swanson P, Temple L, Tepper JE, Thorp R, Vakiani E, Weiser MR, Willis JE, Witkin G, Zeng Z, Zinner MJ, Zornig C, Jensen MA, Sfeir R, Kahn AB, Chu AL, Kothiyal P, Wang Z, Snyder EE, Pontius J, Pihl TD, Ayala B, Backus M, Walton J, Whitmore J, Baboud J, Berton DL, Nicholls MC, Srinivasan D, Raman R, Girshik S, Kigonya PA, Alonso S, Sanbhadti RN, Barletta SP, Greene JM, Pot DA, Shaw KR, Dillon LA, Buetow K, Davidsen T, Demchok JA, Eley G, Ferguson M, Fielding P, Schaefer C, Sheth M, Yang L, Guyer MS, Ozenberger BA, Palchik JD, Peterson J, Sofia HJ, Thomson E., Nature 487(7407), 2012
PMID: 22810696
Methylation subtypes and large-scale epigenetic alterations in gastric cancer.
Zouridis H, Deng N, Ivanova T, Zhu Y, Wong B, Huang D, Wu YH, Wu Y, Tan IB, Liem N, Gopalakrishnan V, Luo Q, Wu J, Lee M, Yong WP, Goh LK, Teh BT, Rozen S, Tan P., Sci Transl Med 4(156), 2012
PMID: 23076357
ENCODE data in the UCSC Genome Browser: year 5 update.
Rosenbloom KR, Sloan CA, Malladi VS, Dreszer TR, Learned K, Kirkup VM, Wong MC, Maddren M, Fang R, Heitner SG, Lee BT, Barber GP, Harte RA, Diekhans M, Long JC, Wilder SP, Zweig AS, Karolchik D, Kuhn RM, Haussler D, Kent WJ., Nucleic Acids Res. 41(Database issue), 2012
PMID: 23193274
Discovery of cross-reactive probes and polymorphic CpGs in the Illumina Infinium HumanMethylation450 microarray.
Chen YA, Lemire M, Choufani S, Butcher DT, Grafodatskaya D, Zanke BW, Gallinger S, Hudson TJ, Weksberg R., Epigenetics 8(2), 2013
PMID: 23314698
Exome and whole-genome sequencing of esophageal adenocarcinoma identifies recurrent driver events and mutational complexity.
Dulak AM, Stojanov P, Peng S, Lawrence MS, Fox C, Stewart C, Bandla S, Imamura Y, Schumacher SE, Shefler E, McKenna A, Carter SL, Cibulskis K, Sivachenko A, Saksena G, Voet D, Ramos AH, Auclair D, Thompson K, Sougnez C, Onofrio RC, Guiducci C, Beroukhim R, Zhou Z, Lin L, Lin J, Reddy R, Chang A, Landrenau R, Pennathur A, Ogino S, Luketich JD, Golub TR, Gabriel SB, Lander ES, Beer DG, Godfrey TE, Getz G, Bass AJ., Nat. Genet. 45(5), 2013
PMID: 23525077
A data-driven approach to preprocessing Illumina 450K methylation array data.
Pidsley R, Y Wong CC, Volta M, Lunnon K, Mill J, Schalkwyk LC., BMC Genomics 14(), 2013
PMID: 23631413
Signatures of mutational processes in human cancer.
Alexandrov LB, Nik-Zainal S, Wedge DC, Aparicio SA, Behjati S, Biankin AV, Bignell GR, Bolli N, Borg A, Borresen-Dale AL, Boyault S, Burkhardt B, Butler AP, Caldas C, Davies HR, Desmedt C, Eils R, Eyfjord JE, Foekens JA, Greaves M, Hosoda F, Hutter B, Ilicic T, Imbeaud S, Imielinski M, Imielinsk M, Jager N, Jones DT, Jones D, Knappskog S, Kool M, Lakhani SR, Lopez-Otin C, Martin S, Munshi NC, Nakamura H, Northcott PA, Pajic M, Papaemmanuil E, Paradiso A, Pearson JV, Puente XS, Raine K, Ramakrishna M, Richardson AL, Richter J, Rosenstiel P, Schlesner M, Schumacher TN, Span PN, Teague JW, Totoki Y, Tutt AN, Valdes-Mas R, van Buuren MM, van 't Veer L, Vincent-Salomon A, Waddell N, Yates LR; Australian Pancreatic Cancer Genome Initiative; ICGC Breast Cancer Consortium; ICGC MMML-Seq Consortium; ICGC PedBrain, Zucman-Rossi J, Futreal PA, McDermott U, Lichter P, Meyerson M, Grimmond SM, Siebert R, Campo E, Shibata T, Pfister SM, Campbell PJ, Stratton MR, Claviez A, Rosenwald A, Rosenwald A, Borkhardt A, Brors B, Radlwimmer B, Lawerenz C, Lopez C, Langenberger D, Karsch D, Lenze D, Kube D, Leich E, Richter G, Korbel J, Hoell J, Eils J, Hezaveh K, Trumper L, Rosolowski M, Weniger M, Rohde M, Kreuz M, Loeffler M, Schilhabel M, Dreyling M, Hansmann ML, Hummel M, Szczepanowski M, Ammerpohl O, Stadler PF, Moller P, Kuppers R, Haas S, Eberth S, Schreiber S, Bernhart SH, Hoffmann S, Radomski S, Kostezka U, Klapper W, Sotiriou C, Larsimont D, Vincent D, Maetens M, Mariani O, Sieuwerts AM, Martens JW, Jonasson JG, Treilleux I, Thomas E, Mac Grogan G, Mannina C, Arnould L, Burillier L, Merlin JL, Lefebvre M, Bibeau F, Massemin B, Penault-Llorca F, Lopez Q, Mathieu MC, Lonning PE, Schlooz-Vries M, Tol J, van Laarhoven H, Sweep F, Bult P., Nature 500(7463), 2013
PMID: 23945592
The cancer biology of whole-chromosome instability.
Duijf PH, Benezra R., Oncogene 32(40), 2013
PMID: 23318433
Genome-wide methylation analysis shows similar patterns in Barrett's esophagus and esophageal adenocarcinoma.
Xu E, Gu J, Hawk ET, Wang KK, Lai M, Huang M, Ajani J, Wu X., Carcinogenesis 34(12), 2013
PMID: 23996928
The degree of segmental aneuploidy measured by total copy number abnormalities predicts survival and recurrence in superficial gastroesophageal adenocarcinoma.
Davison JM, Yee M, Krill-Burger JM, Lyons-Weiler MA, Kelly LA, Sciulli CM, Nason KS, Luketich JD, Michalopoulos GK, LaFramboise WA., PLoS ONE 9(1), 2014
PMID: 24454681
Reducing the risk of false discovery enabling identification of biologically significant genome-wide methylation status using the HumanMethylation450 array.
Naeem H, Wong NC, Chatterton Z, Hong MK, Pedersen JS, Corcoran NM, Hovens CM, Macintyre G., BMC Genomics 15(), 2014
PMID: 24447442
Minfi: a flexible and comprehensive Bioconductor package for the analysis of Infinium DNA methylation microarrays.
Aryee MJ, Jaffe AE, Corrada-Bravo H, Ladd-Acosta C, Feinberg AP, Hansen KD, Irizarry RA., Bioinformatics 30(10), 2014
PMID: 24478339
Vaccines and melanoma.
Ott PA, Fritsch EF, Wu CJ, Dranoff G., Hematol. Oncol. Clin. North Am. 28(3), 2014
PMID: 24880947
Genome-wide DNA methylation patterns in pancreatic ductal adenocarcinoma reveal epigenetic deregulation of SLIT-ROBO, ITGA2 and MET signaling.
Nones K, Waddell N, Song S, Patch AM, Miller D, Johns A, Wu J, Kassahn KS, Wood D, Bailey P, Fink L, Manning S, Christ AN, Nourse C, Kazakoff S, Taylor D, Leonard C, Chang DK, Jones MD, Thomas M, Watson C, Pinese M, Cowley M, Rooman I, Pajic M; APGI, Butturini G, Malpaga A, Corbo V, Crippa S, Falconi M, Zamboni G, Castelli P, Lawlor RT, Gill AJ, Scarpa A, Pearson JV, Biankin AV, Grimmond SM., Int. J. Cancer 135(5), 2014
PMID: 24500968
Ordering of mutations in preinvasive disease stages of esophageal carcinogenesis.
Weaver JMJ, Ross-Innes CS, Shannon N, Lynch AG, Forshew T, Barbera M, Murtaza M, Ong CJ, Lao-Sirieix P, Dunning MJ, Smith L, Smith ML, Anderson CL, Carvalho B, O'Donovan M, Underwood TJ, May AP, Grehan N, Hardwick R, Davies J, Oloumi A, Aparicio S, Caldas C, Eldridge MD, Edwards PAW, Rosenfeld N, Tavare S, Fitzgerald RC; OCCAMS consortium, Hayes SJ, Yeng A, Lydon AM, Dharmaprasad S, Greer S, Preston S, Oakes S, Save V, Paterson-Brown S, Tucker O, Alderson D, Taniere P, Kelly J, Byrne J, Sharland D, Holling N, Boulter L, Noble F, Stacey B, Crichton C, Barr H, Shepherd N, Almond LM, Old O, Lagergren J, Gossage J, Davies A, Mason R, Chang F, Zylstra J, Sanders G, Wheatley T, Berrisford R, Bracey T, Harden C, Bunting D, Roques T, Nobes J, Loo S, Lewis M, Cheong E, Priest O, Parsons SL, Soomro I, Kaye P, Saunders J, Pang V, Welch NT, Catton JA, Duffy JP, Ragunath K, Lovat L, Haidry R, Miah H, Kerr S, Eneh V, Butawan R, Igali L, Ford H, Gilligan D, Safranek P, Hindmarsh A, Sudjendran V, Metz A, Carroll N, Scott M, Cluroe A, Miremadi A, Mahler-Araujo B, Knight O, Nutzinger B, Peters C, Abdullahi Z, Debriram-Beecham I, Malhotra S, Crawte J, MacRae S, Noorani A, Elliott RF, Li X, Bower L, Achilleos A, Bornschein J, Zeki S, Chettouh H, Secrier M, de Silva N, Gregson E, Yang TP, O'Neil JR., Nat. Genet. 46(8), 2014
PMID: 24952744
Comprehensive molecular characterization of gastric adenocarcinoma.
Cancer Genome Atlas Research Network, Bass AJ, Thorsson V, Shmulevich I, Reynolds SM, Miller M, Bernard B, Hinoue T, Laird PW, Curtis C, Shen H, Weisenberger DJ, Schultz N, Shen R, Weinhold N, Kelsen DP, Bowlby R, Chu A, Kasaian K, Mungall AJ, Robertson AG, Sipahimalani P, Cherniack AD, Getz G, Liu Y, Noble MS, Pedamallu C, Sougnez C, Taylor-Weiner A, Akbani R, Lee JS, Liu W, Mills GB, Yang D, Zhang W, Pantazi A, Parfenov M, Gulley M, Piazuelo MB, Schneider BG, Kim J, Boussioutas A, Sheth M, Demchok JA, Rabkin CS, Willis JE, Ng S, Garman K, Beer DG, Pennathur A, Raphael BJ, Wu HT, Odze R, Kim HK, Bowen J, Leraas KM, Lichtenberg TM, Weaver S, McLellan M, Wiznerowicz M, Sakai R, Getz G, Sougnez C, Lawrence MS, Cibulskis K, Lichtenstein L, Fisher S, Gabriel SB, Lander ES, Ding L, Niu B, Ally A, Balasundaram M, Birol I, Bowlby R, Brooks D, Butterfield YS, Carlsen R, Chu A, Chu J, Chuah E, Chun HJ, Clarke A, Dhalla N, Guin R, Holt RA, Jones SJ, Kasaian K, Lee D, Li HA, Lim E, Ma Y, Marra MA, Mayo M, Moore RA, Mungall AJ, Mungall KL, Ming Nip K, Robertson AG, Schein JE, Sipahimalani P, Tam A, Thiessen N, Beroukhim R, Carter SL, Cherniack AD, Cho J, Cibulskis K, DiCara D, Frazer S, Fisher S, Gabriel SB, Gehlenborg N, Heiman DI, Jung J, Kim J, Lander ES, Lawrence MS, Lichtenstein L, Lin P, Meyerson M, Ojesina AI, Sekhar Pedamallu C, Saksena G, Schumacher SE, Sougnez C, Stojanov P, Tabak B, Taylor-Weiner A, Voet D, Rosenberg M, Zack TI, Zhang H, Zou L, Protopopov A, Santoso N, Parfenov M, Lee S, Zhang J, Mahadeshwar HS, Tang J, Ren X, Seth S, Yang L, Xu AW, Song X, Pantazi A, Xi R, Bristow CA, Hadjipanayis A, Seidman J, Chin L, Park PJ, Kucherlapati R, Akbani R, Ling S, Liu W, Rao A, Weinstein JN, Kim SB, Lee JS, Lu Y, Mills G, Laird PW, Hinoue T, Weisenberger DJ, Bootwalla MS, Lai PH, Shen H, Triche T Jr, Van Den Berg DJ, Baylin SB, Herman JG, Getz G, Chin L, Liu Y, Murray BA, Noble MS, Askoy BA, Ciriello G, Dresdner G, Gao J, Gross B, Jacobsen A, Lee W, Ramirez R, Sander C, Schultz N, Senbabaoglu Y, Sinha R, Sumer SO, Sun Y, Weinhold N, Thorsson V, Bernard B, Iype L, Kramer RW, Kreisberg R, Miller M, Reynolds SM, Rovira H, Tasman N, Shmulevich I, Ng S, Haussler D, Stuart JM, Akbani R, Ling S, Liu W, Rao A, Weinstein JN, Verhaak RG, Mills GB, Leiserson MD, Raphael BJ, Wu HT, Taylor BS, Black AD, Bowen J, Carney JA, Gastier-Foster JM, Helsel C, Leraas KM, Lichtenberg TM, McAllister C, Ramirez NC, Tabler TR, Wise L, Zmuda E, Penny R, Crain D, Gardner J, Lau K, Curely E, Mallery D, Morris S, Paulauskis J, Shelton T, Shelton C, Sherman M, Benz C, Lee JH, Fedosenko K, Manikhas G, Potapova O, Voronina O, Belyaev D, Dolzhansky O, Rathmell WK, Brzezinski J, Ibbs M, Korski K, Kycler W, Lazniak R, Leporowska E, Mackiewicz A, Murawa D, Murawa P, Spychala A, Suchorska WM, Tatka H, Teresiak M, Wiznerowicz M, Abdel-Misih R, Bennett J, Brown J, Iacocca M, Rabeno B, Kwon SY, Penny R, Gardner J, Kemkes A, Mallery D, Morris S, Shelton T, Shelton C, Curley E, Alexopoulou I, Engel J, Bartlett J, Albert M, Park DY, Dhir R, Luketich J, Landreneau R, Janjigian YY, Kelsen DP, Cho E, Ladanyi M, Tang L, McCall SJ, Park YS, Cheong JH, Ajani J, Camargo MC, Alonso S, Ayala B, Jensen MA, Pihl T, Raman R, Walton J, Wan Y, Demchok JA, Eley G, Mills Shaw KR, Sheth M, Tarnuzzer R, Wang Z, Yang L, Zenklusen JC, Davidsen T, Hutter CM, Sofia HJ, Burton R, Chudamani S, Liu J., Nature 513(7517), 2014
PMID: 25079317
Genomic catastrophes frequently arise in esophageal adenocarcinoma and drive tumorigenesis.
Nones K, Waddell N, Wayte N, Patch AM, Bailey P, Newell F, Holmes O, Fink JL, Quinn MCJ, Tang YH, Lampe G, Quek K, Loffler KA, Manning S, Idrisoglu S, Miller D, Xu Q, Waddell N, Wilson PJ, Bruxner TJC, Christ AN, Harliwong I, Nourse C, Nourbakhsh E, Anderson M, Kazakoff S, Leonard C, Wood S, Simpson PT, Reid LE, Krause L, Hussey DJ, Watson DI, Lord RV, Nancarrow D, Phillips WA, Gotley D, Smithers BM, Whiteman DC, Hayward NK, Campbell PJ, Pearson JV, Grimmond SM, Barbour AP., Nat Commun 5(), 2014
PMID: 25351503
CHFR methylation strongly correlates with methylation of DNA damage repair and apoptotic pathway genes in non-small cell lung cancer.
Guo M, Alumkal J, Drachova T, Gao D, Marina SS, Jen J, Herman JG., Discov Med 19(104), 2015
PMID: 25828518
Export

Markieren/ Markierung löschen
Markierte Publikationen

Open Data PUB

Web of Science

Dieser Datensatz im Web of Science®
Quellen

PMID: 26905591
PubMed | Europe PMC

Suchen in

Google Scholar